Elevated plasma norepinephrine after in utero exposure to cocaine and marijuana

Pediatrics

Volumn 99, Issue 4, 1997, Pages 555-559

  Mirochnick, Mark ^a,e   Meyer, Jerrold ^b   Frank, Deborah A ^a   Cabral, Howard ^c   Tronick, Edward Z ^d   Zuckerman, Barry ^a  

^a BOSTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF MASSACHUSETTS   (United States)

^c BOSTON UNIVERSITY   (United States)

^d BOSTON CHILDREN S HOSPITAL   (United States)

^e BOSTON MEDICAL CENTER   (United States)

Author keywords

behavior; catecholamines; cocaine; neonate

Indexed keywords

ADRENALIN; ALCOHOL; CANNABIS; CATECHOLAMINE; COCAINE; DOPA; DOPAMINE; NORADRENALIN;

ADULT; ARTICLE; CANNABIS ADDICTION; CATECHOLAMINE BLOOD LEVEL; CHILD BEHAVIOR; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ABUSE; HUMAN; INFANT; NERVOUS SYSTEM DEVELOPMENT; NEUROTRANSMITTER RELEASE; NEWBORN; NORADRENALIN BLOOD LEVEL; PRENATAL DRUG EXPOSURE; PRIORITY JOURNAL; PROSPECTIVE STUDY; SCORING SYSTEM;

EID: 0030944191     PISSN: 00314005     EISSN: None     Source Type: Journal    
DOI: 10.1542/peds.99.4.555     Document Type: Article

References (47)

1. Zuckerman B, Frank DA, Hingson R, et al. Effects of maternal marijuana and cocaine use on fetal growth. N Engl J Med. 1989;320:762-768
2. Chasnoff IJ, Burns WJ, Schnoll SH, Burns KA. Cocaine use in pregnancy. N Engl J Med. 1985;313:666-669
3. Chasnoff IJ, Burns KA, Burns WJ. Cocaine use in pregnancy: Perinatal morbidity and mortality. Neurotoxicol Teratol. 1987;9:291-293
4. van de Bor M, Walther FJ, Ebrahimi M. Decreased cardiac output in infants of mothers who abused cocaine. Pediatrics. 1990;85:30-32
5. Tronick EZ, Frank DA, Cabral H, Mirochnick M, Zuckerman B. Late dose response effects of prenatal cocaine exposure on newborn neurobehavioral performance. Pediatrics. 1996;98:76-83
6. Ritchie JM, Greene NM. Local anesthesia. In: Gilman AG, Goodman LS, Gilman A, eds. The Pharmacological Basis of Therapeutics. 8th ed. New York, NY: Macmillan; 1993:319-320
7. Wood JR, Plessinger MA, Clark KE. Effect of cocaine on uterine blood flow and fetal oxygenation. JAMA. 1987;257:957-961
8. Spitz H, Rosecan J. Cocaine Abuse: New Directions in Treatment and Research. New York, NY: Bruner/Mazel; 1987
9. Dackis CA, Gold MS. New concepts in cocaine addiction: the dopamine depletion hypothesis. Neurosci Behav Rev. 1985;9:469-477
10. Wyatt RJ, Karoum F, Suddath R, Fawcett R. Persistently decreased brain dopamine levels and cocaine. JAMA. 1988;259:2996
11. Dow-Edwards DL. Long-term neurochemical and neurobehavioral consequences of cocaine use during pregnancy. Ann NY Acad Sci. 1989;562: 280-289
12. Needlman R, Zuckerman B, Anderson G, Mirochnick M, Cohen D. CSF monoamine precursors and metabolites in human neonates following in uutero cocaine exposure. Pediatrics. 1993;92:55-60
13. Mirochnick M, Meyer J, Cole J, Herren T and Zuckerman B. Circulating catecholamines in cocaine-exposed neonates: a pilot study. Pediatrics. 1991;88:481-485
14. Hjemdahl P. Catecholamine measurements by high-performance liquid chromatography. Am J Physiol. 1984;247:E13-E20
15. Anton AH, Sayre DF. A study of the factors affecting the aluminum oxide trihydroxyindole procedure for the analysis of catecholamines. J Pharmacol Exp Ther. 1962;138:360-375
16. Ostrea EM, Parks P, Brady M. Rapid isolation and detection of drugs in meconium of drug-dependent infants. Clin Chem. 1988;34:2372
17. Mirochnick M, Rehm K, Brown E, Frank D, Perez A, Turner A. Revised and expanded method for meconium drug analysis. Pediatr Res. 1992:26
18. Lester BM. Change in stability and neonatal behavior. In: Brazelton TB, Lester BM, eds. New Approaches to Developmental Screening of Infants, New York, NY: Elsevier Sciences Publishing Co; 1983:51-75
19. Ward SLD, Schuetz S, Wachsman L, et al. Elevated plasma norepinephrine levels in infants of substance-abusing mothers. AJDC. 1991;145: 44-48
20. Volpe JJ. Effect of cocaine use on the fetus. N Engl J Med. 1992;327: 399-407
21. Shaul PW, Cha C-J M, Oh W. Neonatal sympathoadrenal response to acute hypoxia: impairment after experimental intrauterine growth retardation. Pediatr Res. 1989;25:466-472
22. Echobichon DJ, Stephens DS. Perinatal development of human blood esterases. Clin Pharmacol Ther. 1973;14:1-7
23. Brock JW, Ng JP, Justice JB. Effect of chronic cocaine on dopamine synthesis in the nucleus accumbens as determined by microdialysis perfusion with NSD-1015. Neurosci Lett. 1990;117:234-239
24. Karoum F, Suddath RL, Wyatt RJ. Chronic cocaine and rat brain catecholamines: long term reduction in hypothalamic and frontal cortex dopamine metabolism. Eur J Pharmacol. 1990;186:1-8
25. Weiss F, Markou A, Lorang MT, Koob GF. Basal extracellular dopamine levels in the nucleus accumbens are decreased during cocaine withdrawal after unlimited-access self-administration. Brain Res. 1992;593: 314-318
26. Sobrian SK, Burton LE, Robinson NL, et al. Neurobehavioral and immunological effects of prenatal cocaine exposure in rat. Pharmacol Biochem Behav. 1990;35:617-629
27. Fung YK, Reed JA, Lau Y-S. Prenatal cocaine exposure fails to modify neurobehavioral responses and the striatal dopaminergic system in newborn rats. Gen Pharmacol. 1989;20:689-693
28. Skagerberg G, Björklund A, Lindvall O, Schmidt RH. Origin and termination of the diencephalo-spinal dopamine system in the rat. Brain Res Bull. 1981;9:237-244
29. 2 receptor agonists and antagonists. J Cardiovasc Pharmacol. 1991;18: 548-555
30. Van de Bor M, Walther FJ, Sims WE. Increased cerebral blood flow velocity in infants of mothers who abuse cocaine. Pediatrics. 1990;85: 733-736
31. Padbury JF, Martinez AM. Sympathoadrenal system activity at birth: Integration of postnatal adaptation. Semin Perinatol. 1988;12:163-172
32. Eliot RJ, Lam R, Leake RD, Hobel CJ, Fisher DA. Plasma catecholamine concentrations in infants at birth and during the first 48 hours of life. J Pediatr. 1980;96:311-315
33. Frank DA, McCarten K, Cabral H, Levenson SM, Zuckerman BZ. Association of heavy in utero cocaine exposure with caudate hemorrhage in term newborns. Pediatr Res. 1994;35:269A
34. 9-tetrahydrocannabinol administration of the plasma catecholamine, β-endorphin, and corticosterone levels and splenic natural killer cell activity in rats. Proc Soc Exp Biol Med. 1985;180: 400-404
35. Rodriquez de Fonseca F, Fernandez-Ruiz JJ, Murphy L, Eldridge JC, Steger RW, Bartke A. Effects of delta-9-tetrahydrocannabinol exposure on adrenal medullary function: evidence of an acute effect and development of tolerance in chronic treatments. Pharmacol Biochem Behav. 1991;40:593-59
36. Gardner EL, Lowinson JL. Marijuana's interaction with brain reward systems: update 1991. Pharmacol Biochem Behav. 1991;40:571-580
37. Dalterio S, Mayfield D, Bartke A, Morgan W. Effects of psychoactive and non-psychoactive cannabinoids on neuroendocrine and testicular responsiveness in mice. Life Sci. 1985;36:1299-1306
38. 9-tetrahydrocannabinol in rats. Neuropharmacology. 1980;19:87-95
39. 9-tetrahydrocannabinol in rats. Neuropharmacology. 1980;19:97-102
40. Ali SF, Newport GD, Scallet AC, Gee KW, Paule MG, Brown RM, Slikker W. Effects of chronic delta-9-tetrahydrocannabinol (THC) administration on neurotransmitter concentrations and receptor binding in the rat brain. Neurotoxicology. 1989;10:491-500
41. Dalterio S, Steger R, Mayfield D, Bartke A. Early cannabinoid exposure influences neuroendocrine and reproductive functions in male mice: I. Prenatal exposure. Pharmacol Biochem Behav. 1984;20:107-113
42. Walters DE, Carr LA. Perinatal exposure to cannabinoids alters neurochemical development in rat brain. Pharmacol Biochem Behav. 1988;29: 213-216
43. Walters DE, Carr LA. Changes in brain catecholamine mechanisms following perinatal exposure to marihuana. Pharmacol Biochem Behav. 1986;25:763-768
44. Gold PW, Goodwin FK, Chrousos GP. Clinical and biochemical manifestations of depression: relation to the neurobiology of stress (part 1). N Engl J Med. 1988;319:348-353
45. Weiss JM, Goodman PA, Losito PG, Corrigan S, Charry J, Bailey W. Behavioral depression produced by an uncontrolled stressor: relation to norepinephrine, dopamine and serotonin levels in various regions of the rat brain. Brain Res Rev. 1981;3:167-205
46. Miller JC, Friedhoff AJ Prenatal neurotransmitter programming of postnatal receptor function. Prog Brain Res. 1988;73:509-522
47. Beeghly M, Tronick EZ. Effects of prenatal exposure to cocaine in early infancy: toxic effects on the process of mutual regulation. Infant Mental Health J. 1995;15:158-166